Agilent/Varian, Inc. deal
This article was originally published in The Gray Sheet
Agilent will pay $1.5 billion, or $52 per share, for scientific instrumentation marketer Varian, Inc. (not to be confused with Varian Medical Systems), the firms announced July 27. The acquisition will establish Agilent as a leader in nuclear magnetic resonance, imaging and vacuum technologies and expand its presence in atomic and molecular spectroscopy, according to the company. The deal is expected to close by year end, after which Agilent CFO Adrian Dillon will be responsible for integrating Varian into Agilent's Bio-Analytical Measurement division. The elimination of duplicate operations following the merger is expected to generate $75 million in annual savings, Agilent said
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.